US Patent Issued to The Regents of the University of California on Feb. 24 for "Broad-spectrum multi-antigen pan-coronavirus vaccine" (California Inventor)

ALEXANDRIA, Va., Feb. 24 -- United States Patent no. 12,558,415, issued on Feb. 24, was assigned to The Regents of the University of California (Oakland, Calif.).

"Broad-spectrum multi-antigen pan-coronavirus vaccine" was invented by Lbachir BenMohamed (Irvine, Calif.).

According to the abstract* released by the U.S. Patent & Trademark Office: "Waning immunity induced by first-generation Spike-alone-based COVID-19 has failed to prevent immune escape by many variants of concern (VOCs) that emerged from 2020 to 2024, resulting in a prolonged COVID-19 pandemic. Thus, a next-generation Coronavirus (CoV) vaccine incorporating highly conserved non-Spike SARS-CoV-2 antigens is described herein. Conserved non-Spike T cell antigens in combination ...